HUP0302293A2 - Rák kezelése aplidin és egy izomvédő szer együttes alkalmazásával - Google Patents

Rák kezelése aplidin és egy izomvédő szer együttes alkalmazásával

Info

Publication number
HUP0302293A2
HUP0302293A2 HU0302293A HUP0302293A HUP0302293A2 HU P0302293 A2 HUP0302293 A2 HU P0302293A2 HU 0302293 A HU0302293 A HU 0302293A HU P0302293 A HUP0302293 A HU P0302293A HU P0302293 A2 HUP0302293 A2 HU P0302293A2
Authority
HU
Hungary
Prior art keywords
aplidine
treatment
muscle
myoprotector
cancers
Prior art date
Application number
HU0302293A
Other languages
English (en)
Inventor
Jean-Pierre Armand
José Maria Fernandez Sousa
Luis Lopez Lazaro
Eric Raymond
Original Assignee
Pharma Mar, S.A.
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from GB0025044A external-priority patent/GB0025044D0/en
Priority claimed from GB0025209A external-priority patent/GB0025209D0/en
Priority claimed from PCT/GB2000/004349 external-priority patent/WO2001035974A2/en
Priority claimed from GB0107373A external-priority patent/GB0107373D0/en
Application filed by Pharma Mar, S.A. filed Critical Pharma Mar, S.A.
Publication of HUP0302293A2 publication Critical patent/HUP0302293A2/hu
Publication of HUP0302293A3 publication Critical patent/HUP0302293A3/hu

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
    • A61K31/205—Amine addition salts of organic acids; Inner quaternary ammonium salts, e.g. betaine, carnitine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/04—Peptides having up to 20 amino acids in a fully defined sequence; Derivatives thereof
    • A61K38/15—Depsipeptides; Derivatives thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Epidemiology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Immunology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)

Abstract

A találmány tárgya eljárás rák kezelésére aplidin és egy izomvédő szeregyüttes alkalmazásával. A találmány tárgya továbbá aplidinvegyületalkalmazása, egy izomvédőszer alkalmazása, továbbá egy aplidinvegyületés egy izomvédő szer együttes alkalmazása ráknak aplidin vagyaplidinanalóg és egy izomvédő szer beadásával történő kezelésére szántgyógyászati készítmény előállítására. Ó
HU0302293A 2000-10-12 2001-10-12 Treatment of cancers by aplidine in conjunction with a myoprotector HUP0302293A3 (en)

Applications Claiming Priority (5)

Application Number Priority Date Filing Date Title
GB0025044A GB0025044D0 (en) 2000-10-12 2000-10-12 Toxicity protection
GB0025209A GB0025209D0 (en) 2000-10-13 2000-10-13 Treatment of cancers
PCT/GB2000/004349 WO2001035974A2 (en) 1999-11-15 2000-11-15 Aplidine treatment of cancers
GB0107373A GB0107373D0 (en) 2001-03-23 2001-03-23 Aplidine
PCT/GB2001/004555 WO2002030441A2 (en) 2000-10-12 2001-10-12 Treatment of cancers by aplidine in conjunction with a myoprotector

Publications (2)

Publication Number Publication Date
HUP0302293A2 true HUP0302293A2 (hu) 2003-11-28
HUP0302293A3 HUP0302293A3 (en) 2006-04-28

Family

ID=27447798

Family Applications (1)

Application Number Title Priority Date Filing Date
HU0302293A HUP0302293A3 (en) 2000-10-12 2001-10-12 Treatment of cancers by aplidine in conjunction with a myoprotector

Country Status (8)

Country Link
EP (1) EP1330254B1 (hu)
JP (1) JP2004510824A (hu)
AU (2) AU2001294024C1 (hu)
CA (1) CA2424823A1 (hu)
DE (1) DE60111858T2 (hu)
HU (1) HUP0302293A3 (hu)
MX (1) MXPA03003230A (hu)
WO (1) WO2002030441A2 (hu)

Families Citing this family (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20030148933A1 (en) 1990-10-01 2003-08-07 Pharma Mar S.A. Derivatives of dehydrodidemnin B
GB9803448D0 (en) 1998-02-18 1998-04-15 Pharma Mar Sa Pharmaceutical formulation
UA76718C2 (uk) 2000-06-30 2006-09-15 Фарма Мар, С.А. Протипухлинні похідні аплідину
BR0114604A (pt) 2000-10-12 2003-10-14 Pharma Mar Sa Tratamento de c‰nceres
US7381703B2 (en) * 2003-03-12 2008-06-03 Dana-Faber Cancer Institute, Inc. Aplidine for multiple myeloma treatment
AU2004220451B2 (en) * 2003-03-12 2010-01-21 Pharma Mar, S.A. Improved antitumoral treatments
EP2029155B1 (en) 2006-02-28 2016-04-13 Pharma Mar S.A. Improved treatment of multiple myeloma
JOP20190254A1 (ar) 2017-04-27 2019-10-27 Pharma Mar Sa مركبات مضادة للأورام

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE3161556D1 (en) * 1980-09-12 1984-01-05 Univ Illinois Novel antibiotics, derivatives thereof, processes for their extraction, and compositions containing them
IT1150396B (it) * 1982-12-09 1986-12-10 Sigma Tau Ind Farmaceuti Impiego di alcanoil l-carnitine per il trattamento terapeutico di miopa tie e distrofie muscolari
GB8922026D0 (en) * 1989-09-29 1989-11-15 Pharma Mar Sa Novel anti-viral and cytotoxic agent
IT1277147B1 (it) * 1995-01-20 1997-11-04 Sigma Tau Ind Farmaceuti Uso della carnitina e i suoi derivati per ridurre gli effetti tossici della ciclosporina-a e di altri farmaci immunosoppressivi.

Also Published As

Publication number Publication date
AU9402401A (en) 2002-04-22
AU2001294024B2 (en) 2006-01-05
WO2002030441A2 (en) 2002-04-18
EP1330254A2 (en) 2003-07-30
WO2002030441A3 (en) 2002-08-01
EP1330254B1 (en) 2005-07-06
JP2004510824A (ja) 2004-04-08
DE60111858T2 (de) 2006-04-20
HUP0302293A3 (en) 2006-04-28
AU2001294024C1 (en) 2006-11-23
DE60111858D1 (de) 2005-08-11
MXPA03003230A (es) 2004-12-03
CA2424823A1 (en) 2002-04-18

Similar Documents

Publication Publication Date Title
AU4550801A (en) Herbal composition phy906 and its use in chemotheraphy
MY129263A (en) Vaccine composition
MY127290A (en) New use of flibanserin
MXPA02011656A (es) Moleculas de acido nucleico nrg-2, polipeptidos, y metodos de diagnostico y terapeuticos.
HUP0203035A2 (hu) Prosztatarák terápiájára és diagnózisára alkalmas vegyületek és eljárások
WO2003096990A3 (en) Protein cages for the delivery of medical imaging and therapy
MXPA05008406A (es) Compuestos de amida tri(ciclo)-sustituida.
GB2431346C (en) A combination composition comprising paracetamol and ibuprofen
AU2001235006A1 (en) Prophylactic and therapeutic monoclonal antibodies
EP1670450B8 (en) Pharmaceutical compositions and method of using levodopa and carbidopa
TW200630105A (en) Herbal composition PHY906 and its use in chemotherapy
HUP0400782A2 (hu) Antikolinergikumokon és PDE-IV inhibitorokon alapuló új gyógyszerkészítmények
EP1505990A4 (en) METHOD FOR THE TREATMENT OF HEPATITIS
IL153680A0 (en) Aplidine derivatives and methods for the preparation thereof
TW200509896A (en) Analeptic and drug combinations
HUP0300848A2 (hu) Kamptotecint és egy pirimidinszármazékot tartalmazó készítmény rák kezelésére
HUP0302293A2 (hu) Rák kezelése aplidin és egy izomvédő szer együttes alkalmazásával
DE50212646D1 (de) Verwendung von selenithältigen verbindungen zur topischen oder bukkalen anwendung
HUP0203906A2 (en) Aplidine treatment of cancers
GB0020504D0 (en) Therapeutic method
HUP0301247A2 (hu) Antitumor terápia disztamicin származékokkal
MXPA02011533A (es) Nuevas formulaciones de alfa-2,4-disulfofenil-n-terc-butilnitrona.
SG156658A1 (en) Treatment of diseases
HK1065305A1 (en) Substituted 4-aminocyclohexanol derivatives
IL174134A0 (en) Use of a protein in the preparation of a medicament for treatment of fibrotic diseases

Legal Events

Date Code Title Description
FD9A Lapse of provisional protection due to non-payment of fees